Topic Paragraphs
FDA Accomplishments for the American People
FDA Takes New Approach to "No Artificial Colors" Claims
The U.S. Food and Drug Administration took additional steps to support the transition of our nation’s food supply from the use of artificial petroleum-based colors to alternatives derived from natural sources. Companies will now have flexibility to claim products contain ‘no artificial colors’ when the products do not contain petroleum-based colors.
Read MoreRecent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Feb 06
Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems
Medical Devices
Feb 03
Prime Food Processing LLC Issues Allergy Alert and Safety Warning Regarding Uneviscerated Dried Croaker Fish
Food & Beverages
Jan 28
Why Not Natural, Houston, Texas, is Recalling its Why Not Natural Organic Moringa - Green Superfood because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
A Special Year, New Seal, and Renewed Commitment to the American People
The FDA has unveiled an official agency seal which signifies the many public health strides made over 120 years.
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
Recently Published Guidances
Feb 06
E22 General Considerations for Patient Preference Studies
Drugs
Feb 03
Computer Software Assurance for Production and Quality Management System Software
Medical Devices
Feb 03
Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
Biologics, Medical Devices